Search Result "PD-L1 inhibitors"


Review Article

Inhibitory Effect of PD-1/PD-L1 and Blockade Immunotherapy inLeukemia

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 25 Issue: 9 Year: 2022 Page: 1399-1410
Author(s): Kai Xing,Pan Zhou,Jiaojiao Li,Miao Liu,Wei Emma Zhang

Mini-Review Article

PD-L1 Inhibitors for the Treatment of Prostate Cancer

Journal: Current Drug Targets
Volume: 21 Issue: 15 Year: 2020 Page: 1558-1565
Author(s): Matteo Santoni,Francesco Massari,Liang Cheng,Alessia Cimadamore,Marina Scarpelli,Rodolfo Montironi,Antonio Lopez-Beltran

Mini-Review Article

PD1 and PD-L1 Inhibitors for the Treatment of Kidney Cancer: The Role of PD-L1 Assay

Journal: Current Drug Targets
Volume: 21 Issue: 16 Year: 2020 Page: 1664-1671
Author(s): Alessia Cimadamore,Francesco Massari,Matteo Santoni,Antonio Lopez-Beltran,Liang Cheng,Marina Scarpelli,Rodolfo Montironi,Holger Moch

Systematic Review Article

Efficacy of PD-1 or PD-L1 Inhibitors and Central Nervous System Metastases in Advanced Cancer: A Meta-Analysis

Journal: Current Cancer Drug Targets
Volume: 21 Issue: 9 Year: 2021 Page: 794-803
Author(s): Minyong Peng,Shan Li,Hui Xiang,Wen Huang,Weiling Mao,Di Xu

Review Article

Current Medicinal Insights on Synthetic Small Molecules and NaturalOrigin Products as PD-1/PD-L1 Inhibitors

Journal: Current Topics in Medicinal Chemistry
Volume: 23 Issue: 18 Year: 2023 Page: 1765-1781
Author(s): Balak Das Kurmi

Review Article

Research Progress of PD 1/PD L1 Inhibitors in the Treatment ofUrological Tumors

Journal: Current Cancer Drug Targets
Volume: 24 Issue: 11 Year: 2024 Page: 1104-1115
Author(s):

Review Article

PD-L1 Signal Transduction Mechanisms in Cancer Cells

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume: 17 Issue: 2 Year: 2017 Page: 72-86
Author(s): Miren Zuazo-Ibarra,Maria Gato-Canas,Hugo Arasanz-Esteban,Gonzalo Fernandez-Hinojal,Maria Ibanez-Vea,Luisa Chocarro,Ruth Vera-Garcia,David Escors,Grazyna Kochan

Mini-Review Article

PD-L1 Testing for Urothelial Carcinoma: Interchangeability, Reliability and Future Perspectives

Journal: Current Drug Targets
Volume: 22 Issue: 2 Year: 2021 Page: 162-170
Author(s): Thomas Gevaert,Alessia Cimadamore,Rodolfo Montironi,Markus Eckstein

Review Article

PD-1/PD-L1 Inhibitors for Immuno-oncology: From Antibodies to Small Molecules

Journal: Current Pharmaceutical Design
Volume: 23 Issue: 39 Year: 2017 Page: 6033-6041
Author(s): Qiaohong Geng,Peifu Jiao,Peng Jin,Gaoxing Su,Jinlong Dong,Bing Yan

Research Article

Occurrence and Severity of Adverse Reactions of Immune CheckpointInhibitors (PD-1 and PD L1) Based on Mordovian Dispensary DataAnalysis

Journal: Current Cancer Therapy Reviews
Volume: 18 Issue: 1 Year: 2022 Page: 51-56
Author(s): Basheer Marzoog

Previous   Next

Go To   Results 1 - 1 of 1028

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy